Rasch analysis informed the development of a classification system for a diabetes-specific preference-based measure of health

Journal of Clinical Epidemiology

Volumn 62, Issue 8, 2009, Pages 845-856

  Sundaram, Murali ^a   Smith, Michael J ^a   Revicki, Dennis A ^b   Elswick, Betsy ^a   Miller, Lesley Ann ^c  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Cost effectiveness; Diabetes; Economic evaluation; Health state preferences; Preference based measure of health; Preferences; QALY; Quality Adjusted Life Year; Rasch analysis; Utility

Indexed keywords

ARTICLE; DIABETES EMPOWERMENT SCALE SHORT FORM; DIABETES MELLITUS; DIABETES UTILITY INDEX; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENERGY; FACTORIAL ANALYSIS; HEALTH STATUS; HEALTH SURVEY; HUMAN; HUMAN RELATION; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL AUDIT; MOOD; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; RASCH ANALYSIS; RELIABILITY; SF 12V2; VALIDATION STUDY; VALIDITY; WELL BEING QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ATTITUDE TO HEALTH; DIABETES MELLITUS; EPIDEMIOLOGIC METHODS; EXPERT TESTIMONY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 67649359506     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2009.01.020     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007 (2008), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
2. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21 (1998) 296-309
3. Rubin R.J., Altman W.M., and Mendelson D.N. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78 (1994) 809A-F
4. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
5. Gold M.R., Patrick D.L., Torrance G.W., Fryback D.G., Hadorn D.C., Kamlet M.S., et al. Identifying and valuing outcomes. In: Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. (Eds). Cost-effectiveness in health and medicine (1996), Oxford University Press, New York, NY 82-134
6. Drummond M.F., O'Brien B.J., Stoddart G.L., and Torrance G.W. Cost-utility analysis. Methods for the economic evaluation of healthcare programs (1997), Oxford University Press, New York, NY pp. 139-204
7. Brooks R. EuroQol: the current state of play. Health Policy 37 1 (1996) 53-72
8. Kind P. The EuroQoL instrument: an index of health-related quality of life. In: Spilker B. (Ed). Quality of life and pharmacoeconomics in clinical trials (1996), Lippincott-Raven, Philadelphia, PA 191-201
9. Feeny D., Furlong W., Boyle M., and Torrance G.W. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 7 6 (1995) 490-502
10. Torrance G.W., Feeny D.H., Furlong W.J., Barr R.D., Zhang Y., and Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care 34 (1996) 702-722
11. Feeny D., Furlong W., Torrance G.W., Goldsmith C.H., Zhu Z., DePauw S., et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 40 2 (2002) 113-128
12. Kaplan R.M., and Anderson J.P. A general health policy model: update and applications. Health Serv Res 23 (1988) 203-235
13. Kaplan R.M., and Anderson J.P. The general health policy model: and integrated approach. In: Spilker B. (Ed). Quality of life and pharmacoeconomics in clinical trials (1996), Lippincott-Raven, Philadelphia, PA 302-322
14. Brazier J., Roberts J., and Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 21 (2002) 271-292
15. Brazier J.E., and Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 42 9 (2004) 851-859
16. Kantz M.E., Harris W.J., Levitsky K., Ware Jr. J.E., and Davies A.R. Methods for assessing condition-specific and generic functional status outcomes after total knee replacement. Med Care 30 Suppl 5 (1992) 240-252
17. Bombardier C., Melfi C.A., Paul J., Green R., Hawker G., Wright J., et al. Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery. Med Care 33 Suppl 4 (1995) 131-144
18. Revicki D.A., Leidy N.K., Brennan-Diemer F., Thompson C., and Togias A. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 7 8 (1998) 693-702
19. Revicki D.A., Leidy N.K., Brennan-Diemer F., Sorensen S., and Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 114 (1998) 998-1007
20. Brazier J.E., Roberts J., Platts M., and Zoellner Y.F. Estimating a preference-based index for a menopause specific health quality of life questionnaire. Health Qual Life Outcomes 3 1 (2005) 13
21. Polonsky W.H. Understanding and assessing diabetes-specific quality of life. Diabetes Spectr 13 1 (2000) 36-41
22. Sundaram M., Kavookjian J., Patrick J.H., Miller L.A., Madhavan S.S., and Scott V.G. Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res 16 2 (2006) 165-177
23. Bradley C., Todd C., Gorton T., Symonds E., Martin A., and Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 8 1-2 (1999) 79-91
24. Bradley C., and Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 18 Suppl 3 (2002) S64-S69
25. Prieto L., Alonso J., and Lamarca R. Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health Qual Life Outcomes 1 1 (2003) 27
26. SPSS. SPSS for Windows (Rel. 15.0.1.). [Computer Software] (2007), SPSS Inc., Chicago
27. O'Connor R. Measuring quality of life in health (2004), Churchill Livingstone
28. Linacre M. Winsteps (Version 3.63.2). [Computer Software] (2007), Winsteps.com, Chicago
29. Wright B.D., and Linacre M. Reasonable mean-square fit values. Rasch Meas Trans 8 (1994) 370
30. Smith R.M. Polytomous mean-square fit statistics. Rasch Meas Trans 10 (1996) 516-517
31. Smith R.M., Schumacker R.E., and Bush M.J. Using item mean squares to evaluate fit to the Rasch model. J Outcome Meas 2 1 (1998) 66-78
32. Linacre J.M. Investigating rating scale category utility. J Outcome Meas 3 2 (1999) 103-122
33. Wright B.D., and Linacre M. Reliability and separation. Rasch Meas Trans 9 4 (1996) 72
34. Ware Jr. J., Kosinski M., and Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 3 (1996) 220-233
35. Bradley C. The Well-Being Questionnaire. In: Bradley C. (Ed). Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice (1994), Harwood Academic Publishers, Switzerland 89-109
36. Bradley C. The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability. Diabetes Care 23 6 (2000) 875
37. Anderson R.M., Funnell M.M., Fitzgerald J.T., and Marrero D.G. The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care 23 (2000) 739-743
38. Anderson R.M., Fitzgerald J.T., Gruppen L.D., Funnell M.M., and Oh M.S. The Diabetes Empowerment Scale-Short Form (DES-SF). Diabetes Care 26 (2003) 1641-1642
39. Tennant A., and Pallant J.F. Unidimensionality Matters! (A Tale of Two Smiths?). Rasch Meas Trans 20 (2006) 1048-1051
40. Smith R.M. A comparison of methods for determining dimensionality in Rasch measurement. Struct Equation Model 3 (1996) 25-40
41. Smith Jr. E.V. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 3 (2002) 205-231
42. Juniper E.F., Guyatt G.H., and Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B. (Ed). Quality of life and pharmacoeconomics in clinical trials (1996), Lippincott-Raven, Philadelphia, PA 49-56
43. Juniper E.F., Guyatt G.H., Streiner D.L., and King D.R. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 50 3 (1997) 233-238
44. Russell L.B., Gold M.R., Siegel J.E., Daniels N., and Weinstein M.C. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. JAMA 276 14 (1996) 1172-1177
45. Weinstein M.C., Siegel J.E., Gold M.R., Kamlet M.S., and Russell L.B. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276 15 (1996) 1253-1258
46. Siegel J.E., Weinstein M.C., Russell L.B., and Gold M.R. Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. JAMA 276 16 (1996) 1339-1341